These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 23633482)
1. Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production. Hiraga T; Ito S; Nakamura H Cancer Res; 2013 Jul; 73(13):4112-22. PubMed ID: 23633482 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo. Urakawa H; Nishida Y; Wasa J; Arai E; Zhuo L; Kimata K; Kozawa E; Futamura N; Ishiguro N Int J Cancer; 2012 Jan; 130(2):454-66. PubMed ID: 21387290 [TBL] [Abstract][Full Text] [Related]
3. HAS3-related hyaluronan enhances biological activities necessary for metastasis of osteosarcoma cells. Tofuku K; Yokouchi M; Murayama T; Minami S; Komiya S Int J Oncol; 2006 Jul; 29(1):175-83. PubMed ID: 16773198 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer. Urakawa H; Nishida Y; Knudson W; Knudson CB; Arai E; Kozawa E; Futamura N; Wasa J; Ishiguro N J Orthop Res; 2012 Apr; 30(4):662-72. PubMed ID: 21913222 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44. Golshani R; Lopez L; Estrella V; Kramer M; Iida N; Lokeshwar VB Cancer Res; 2008 Jan; 68(2):483-91. PubMed ID: 18199543 [TBL] [Abstract][Full Text] [Related]
6. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration. Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740 [TBL] [Abstract][Full Text] [Related]
7. Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane. Saito T; Kawana H; Azuma K; Toyoda A; Fujita H; Kitagawa M; Harigaya K Int J Oncol; 2011 Nov; 39(5):1311-20. PubMed ID: 21743962 [TBL] [Abstract][Full Text] [Related]
9. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Zhu H; Mitsuhashi N; Klein A; Barsky LW; Weinberg K; Barr ML; Demetriou A; Wu GD Stem Cells; 2006 Apr; 24(4):928-35. PubMed ID: 16306150 [TBL] [Abstract][Full Text] [Related]
10. Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6. Lin JT; Wang JY; Chen MK; Chen HC; Chang TH; Su BW; Chang PJ Exp Cell Res; 2013 Aug; 319(14):2216-29. PubMed ID: 23751564 [TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-2 stimulates directed migration of periodontal ligament cells via PI3K/AKT signaling and CD44/hyaluronan interaction. Shimabukuro Y; Terashima H; Takedachi M; Maeda K; Nakamura T; Sawada K; Kobashi M; Awata T; Oohara H; Kawahara T; Iwayama T; Hashikawa T; Yanagita M; Yamada S; Murakami S J Cell Physiol; 2011 Mar; 226(3):809-21. PubMed ID: 20857427 [TBL] [Abstract][Full Text] [Related]
12. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion. Afify A; Purnell P; Nguyen L Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378 [TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice. Piccioni F; Malvicini M; Garcia MG; Rodriguez A; Atorrasagasti C; Kippes N; Piedra Buena IT; Rizzo MM; Bayo J; Aquino J; Viola M; Passi A; Alaniz L; Mazzolini G Glycobiology; 2012 Mar; 22(3):400-10. PubMed ID: 22038477 [TBL] [Abstract][Full Text] [Related]
14. Extensive CD44-dependent hyaluronan coats on human bone marrow-derived mesenchymal stem cells produced by hyaluronan synthases HAS1, HAS2 and HAS3. Qu C; Rilla K; Tammi R; Tammi M; Kröger H; Lammi MJ Int J Biochem Cell Biol; 2014 Mar; 48():45-54. PubMed ID: 24406795 [TBL] [Abstract][Full Text] [Related]
15. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion. Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741 [TBL] [Abstract][Full Text] [Related]
16. Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. Spessotto P; Rossi FM; Degan M; Di Francia R; Perris R; Colombatti A; Gattei V J Cell Biol; 2002 Sep; 158(6):1133-44. PubMed ID: 12235127 [TBL] [Abstract][Full Text] [Related]
17. Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization. Mochimaru H; Takahashi E; Tsukamoto N; Miyazaki J; Yaguchi T; Koto T; Kurihara T; Noda K; Ozawa Y; Ishimoto T; Kawakami Y; Tanihara H; Saya H; Ishida S; Tsubota K Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4410-5. PubMed ID: 19339747 [TBL] [Abstract][Full Text] [Related]
18. Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer. Zou L; Song X; Yi T; Li S; Deng H; Chen X; Li Z; Bai Y; Zhong Q; Wei Y; Zhao X Cancer Gene Ther; 2013 Apr; 20(4):242-50. PubMed ID: 23492823 [TBL] [Abstract][Full Text] [Related]
19. MGr1-Ag promotes invasion and bone metastasis of small-cell lung cancer in vitro and in vivo. Zhang F; Wang Y; Xu M; Dong H; Liu N; Zhou J; Pang H; Ma N; Zhang N; Pei Y; Zhang H; Liu L Oncol Rep; 2013 Jun; 29(6):2283-90. PubMed ID: 23588894 [TBL] [Abstract][Full Text] [Related]
20. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]